Lv1
20 积分 2024-04-05 加入
Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial
2个月前
已完结
Haematopoietic stem cell number is not solely defined by niche availability
3个月前
已完结
Incidence, Risk Factors, and Outcomes of Primary Prolonged Isolated Thrombocytopenia after Haploidentical Hematopoietic Stem Cell Transplant
3个月前
已完结
Eltrombopag is an effective and safe therapy for refractory thrombocytopenia after haploidentical hematopoietic stem cell transplantation
3个月前
已完结
Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy
4个月前
已完结
Anti-CD25 monoclonal antibody (basiliximab) for prevention of graft-versus-host disease after haploidentical bone marrow transplantation for hematological malignancies
4个月前
已完结
Efficacy and Safety of Hetrombopag Versus Thrombopoietin in Promoting Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective, Multicenter, Randomized Controlled Clinical Trial
7个月前
已完结
Herombopag for the treatment of persistent thrombocytopenia following hematopoietic stem cell transplantation
7个月前
已完结
Anti-CD25 monoclonal antibody coverage allows for calcineurin inhibitor ???holiday??? in solid organ transplant patients with acute renal dysfunction1
10个月前
已完结
Hematopoietic Cell Transplantation, Version 3.2025, NCCN Clinical Practice Guidelines In Oncology
11个月前
已关闭
皖公网安备34019202002308
